Bausch & Lomb (BLCO) Current Assets (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Current Assets came in at $2.9 billion in Q2 2026, up 2.67% on a YoY basis from $2.8 billion in Q2 2025, and up 5.26% quarter-over-quarter from $2.8 billion in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Current Assets (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Current Assets for 6 consecutive years, with $2.9 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Assets rose 2.67% year-over-year to $2.9 billion; the trailing twelve-month figure through Jun 2026 stood at $2.9 billion (up 2.67% YoY), and the FY2025 full-year result was $3.0 billion, up 6.78% from the prior year.
- Current Assets rose to $2.9 billion in Q2 2026 per BLCO's latest filing, from $2.8 billion in the prior quarter.
- Across five years, Current Assets topped out at $3.0 billion in Q4 2025 and bottomed at $1.7 billion in Q1 2022.
- Historically, Current Assets has averaged $2.5 billion across 5 years, with a median of $2.7 billion in 2023.
- The sharpest annual moves came in 2023 and 2025: Current Assets soared 32.54% in 2023, then dropped 1.79% in 2025.
- Over 5 years, Current Assets stood at $2.1 billion in 2022, then climbed by 28.31% to $2.7 billion in 2023, then increased by 1.68% to $2.8 billion in 2024, then increased by 6.78% to $3.0 billion in 2025, then decreased by 1.85% to $2.9 billion in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $2.9 billion, $2.8 billion, and $3.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 9.54 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 24.39 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 14.42 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 7.97 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 6.82 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.62 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 4.09 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 2.92 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.92 Bn |
| Mar 31, 2026 | 2.78 Bn |
| Dec 31, 2025 | 2.98 Bn |
| Sep 30, 2025 | 2.86 Bn |
| Jun 30, 2025 | 2.85 Bn |
| Mar 31, 2025 | 2.69 Bn |
| Dec 31, 2024 | 2.79 Bn |
| Sep 30, 2024 | 2.83 Bn |
| Jun 30, 2024 | 2.77 Bn |
| Mar 31, 2024 | 2.74 Bn |
| Dec 31, 2023 | 2.74 Bn |
| Sep 30, 2023 | 2.46 Bn |
| Jun 30, 2023 | 2.32 Bn |
| Mar 31, 2023 | 2.18 Bn |
| Dec 31, 2022 | 2.14 Bn |
| Sep 30, 2022 | 1.86 Bn |
| Jun 30, 2022 | 2.00 Bn |
| Mar 31, 2022 | 1.72 Bn |
| Dec 31, 2021 | 1.64 Bn |